Citigroup has raised the price target on CVS Caremark (NYSE:
CVS) from $41 to $46 and maintains its Buy rating.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
